EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
MIT Technology Review·Aug 27·5 min read
A startup claims it’s found a drug to make your blood young
TL;DR
Generation Lab claims to have developed 1-Generation, an injectable treatment combining two existing drugs that purportedly rejuvenates blood and tissues. However, the lack of transparency about the drugs raises skepticism about its effectiveness.
✦ Why It Matters
Consider researching the scientific basis of longevity treatments before investing time or money.
Key Takeaways
- Investigate the components of any longevity treatment before use.
- Be cautious of clinical trials requiring payment from participants.
- Evaluate the credibility of practitioners involved in alternative medicine.
- Stay informed about advancements in biotechnology and longevity research.
How It Works
1-Generation is designed to mimic the rejuvenating effects observed in animal studies where young and old circulatory systems are connected. By using a microfluidic device, researchers can test how existing drugs affect human cells in the presence of old blood serum, aiming to stimulate regeneration and neutralize aging factors.
⚠ The Catch
The lack of transparency regarding the drug components and the requirement for participants to pay for the clinical trial raises significant concerns about the validity and motivations behind the study.